ID27535A - Turunan pirasola sebagai inhibitor p-38 map kinase - Google Patents
Turunan pirasola sebagai inhibitor p-38 map kinaseInfo
- Publication number
- ID27535A ID27535A IDW20002241A ID20002241A ID27535A ID 27535 A ID27535 A ID 27535A ID W20002241 A IDW20002241 A ID W20002241A ID 20002241 A ID20002241 A ID 20002241A ID 27535 A ID27535 A ID 27535A
- Authority
- ID
- Indonesia
- Prior art keywords
- map kinase
- pirasola
- duration
- kinase inhibitor
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/44—Oxygen and nitrogen or sulfur and nitrogen atoms
- C07D231/52—Oxygen atom in position 3 and nitrogen atom in position 5, or vice versa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8425098P | 1998-05-05 | 1998-05-05 | |
US12241099P | 1999-03-02 | 1999-03-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
ID27535A true ID27535A (id) | 2001-04-12 |
Family
ID=26770756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW20002241A ID27535A (id) | 1998-05-05 | 1999-04-28 | Turunan pirasola sebagai inhibitor p-38 map kinase |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP1075467B1 (id) |
JP (1) | JP3590586B2 (id) |
KR (1) | KR100404256B1 (id) |
CN (1) | CN1147476C (id) |
AT (1) | ATE292118T1 (id) |
AU (1) | AU765030B2 (id) |
BR (1) | BR9911013A (id) |
CA (1) | CA2329065A1 (id) |
DE (1) | DE69924480D1 (id) |
HK (1) | HK1037374A1 (id) |
HR (1) | HRP20000724A2 (id) |
HU (1) | HUP0101581A3 (id) |
ID (1) | ID27535A (id) |
IL (1) | IL139169A0 (id) |
MA (1) | MA26627A1 (id) |
NO (1) | NO317985B1 (id) |
NZ (1) | NZ507558A (id) |
PL (1) | PL344004A1 (id) |
RU (1) | RU2000130199A (id) |
TR (1) | TR200003256T2 (id) |
TW (1) | TW593282B (id) |
WO (1) | WO1999057101A1 (id) |
YU (1) | YU67600A (id) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1023066A4 (en) | 1997-06-13 | 2001-05-23 | Smithkline Beecham Corp | NEW PYRAZOLE AND PYRAZOLINE SUBSTITUTED COMPOUND |
US7301021B2 (en) | 1997-07-02 | 2007-11-27 | Smithkline Beecham Corporation | Substituted imidazole compounds |
US6316466B1 (en) * | 1998-05-05 | 2001-11-13 | Syntex (U.S.A.) Llc | Pyrazole derivatives P-38 MAP kinase inhibitors |
HUP0104693A3 (en) * | 1998-12-16 | 2003-12-29 | Warner Lambert Co | Treatment of arthritis with mek inhibitors |
CN101481359A (zh) | 1999-04-15 | 2009-07-15 | 布里斯托尔-迈尔斯斯奎布公司 | 环状蛋白酪氨酸激酶抑制剂 |
US7125875B2 (en) | 1999-04-15 | 2006-10-24 | Bristol-Myers Squibb Company | Cyclic protein tyrosine kinase inhibitors |
US6472528B1 (en) | 1999-08-10 | 2002-10-29 | Neurocrine Biosciences, Inc. | Synthesis of substituted pyrazolopyrimidines |
US6399621B1 (en) | 1999-08-10 | 2002-06-04 | American Cyanamid Company | N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
US6485746B1 (en) | 2000-08-25 | 2002-11-26 | Neurocrine Biosciences, Inc. | Controlled-release sedative-hypnotic compositions and methods related thereto |
US6384221B1 (en) | 1999-09-02 | 2002-05-07 | Neurocrine Biosciences, Inc. | Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
JP2003514899A (ja) | 1999-11-23 | 2003-04-22 | スミスクライン・ビーチャム・コーポレイション | CSBP/p38キナーゼ阻害剤としての3,4‐ジヒドロ−(1H)−キナゾリン−2−オン化合物 |
AU784813B2 (en) * | 2000-01-17 | 2006-06-29 | Bayer Aktiengesellschaft | Substituted aryl ketones |
CA2401697A1 (en) | 2000-03-03 | 2001-09-07 | Pfizer Products Inc. | Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
CN100494182C (zh) | 2000-05-12 | 2009-06-03 | 基酶有限公司 | 肿瘤坏死α因子信号的调节因子 |
CA2419820A1 (en) | 2000-08-17 | 2002-02-21 | Lumera Corporation | Design and synthesis of advanced nlo materials for electro-optic applications |
CZ20022642A3 (cs) * | 2001-08-27 | 2003-09-17 | Pfizer Products Inc. | Způsob výroby dialkylpyridylboranů |
AU2002331179B2 (en) | 2001-08-30 | 2008-04-17 | F. Hoffmann-La Roche Ag | Aminopyrrole compounds as antiinflammatory agents |
EP1707205A2 (en) | 2002-07-09 | 2006-10-04 | Boehringer Ingelheim Pharma GmbH & Co. KG | Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
JP2006508051A (ja) | 2002-08-29 | 2006-03-09 | サイオス インク. | 骨形成を促進する方法 |
AU2003266617B2 (en) * | 2002-09-25 | 2009-01-29 | Ube Industries, Ltd. | Pyrazole compounds |
NZ544230A (en) | 2003-06-26 | 2009-07-31 | Novartis Ag | 5-Membered heterocycle-based P38 kinase inhibitors |
US7244441B2 (en) | 2003-09-25 | 2007-07-17 | Scios, Inc. | Stents and intra-luminal prostheses containing map kinase inhibitors |
EP2336113A1 (en) | 2004-05-29 | 2011-06-22 | 7TM Pharma A/S | CRTH2 Receptor Ligands for Medical Use |
US20060035893A1 (en) | 2004-08-07 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
PE20060777A1 (es) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
GB0513297D0 (en) * | 2005-06-29 | 2005-08-03 | Glaxo Group Ltd | Novel compounds |
GB0603684D0 (en) * | 2006-02-23 | 2006-04-05 | Novartis Ag | Organic compounds |
WO2008000777A2 (en) * | 2006-06-29 | 2008-01-03 | Glaxo Group Limited | Phenyl- pyrazole derivatives, process for their preparation and their pharmaceutical use |
GB0621978D0 (en) * | 2006-11-03 | 2006-12-13 | Chroma Therapeutics Ltd | Inhibitors of p38 mitogen-activated protein kinase |
EP1992344A1 (en) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation |
AR084370A1 (es) * | 2009-08-07 | 2013-05-15 | Chugai Pharmaceutical Co Ltd | Derivados de aminopirazol |
JP2011201794A (ja) * | 2010-03-24 | 2011-10-13 | Fujifilm Corp | 5−アミノピラゾール誘導体及びその塩の製造方法 |
JP5620417B2 (ja) * | 2011-02-07 | 2014-11-05 | 中外製薬株式会社 | アミノピラゾール誘導体を含む医薬 |
BR112016004723B1 (pt) * | 2013-09-03 | 2022-08-30 | Sareum Limited | Compostos de pirrolidina ou morfolina e composição contendo os mesmos |
DK3087986T3 (da) | 2013-12-27 | 2019-12-02 | Chugai Pharmaceutical Co Ltd | Mutant fgfr-gatekeepergen og aktivt stof rettet mod samme |
WO2016204261A1 (ja) | 2015-06-17 | 2016-12-22 | 中外製薬株式会社 | アミノピラゾール誘導体 |
GB201612238D0 (en) * | 2016-07-14 | 2016-08-31 | Mereo Biopharma 1 Ltd | Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-Yl]-n-cyclopropyl-4-methylbenzamide |
GB201612240D0 (en) | 2016-07-14 | 2016-08-31 | Mereo Biopharma 1 Ltd | Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide |
WO2018059533A1 (zh) * | 2016-09-29 | 2018-04-05 | 南京明德新药研发股份有限公司 | p38αMAPK激酶抑制剂及其制备方法和应用 |
US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
WO2019071147A1 (en) | 2017-10-05 | 2019-04-11 | Fulcrum Therapeutics, Inc. | INHIBITORS OF KINASE P38 REDUCING EXPRESSION OF DUX4 GENE AND DOWNSTREAM GENES FOR THE TREATMENT OF FSHD |
EP3563848A1 (en) * | 2018-04-30 | 2019-11-06 | S.I.S.S.A. Scuola Internazionale Superiore di Studi Avanzati | Serpin inhibitors for the treatment of prion and prion-like diseases |
GB201815695D0 (en) * | 2018-09-26 | 2018-11-07 | Mereo Biopharma 1 Ltd | Synthetic method |
GB201815699D0 (en) * | 2018-09-26 | 2018-11-07 | Mereo Biopharma 1 Ltd | Synthetic method |
WO2020102098A1 (en) * | 2018-11-13 | 2020-05-22 | Novartis Inflammasome Research, Inc. | Compounds and compositions for treating conditions associated with nlrp activity |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2150483C (en) * | 1992-12-17 | 1999-09-14 | Pfizer Limited | Pyrazoles and pyrazolopyrimidines |
-
1999
- 1999-04-28 AU AU40348/99A patent/AU765030B2/en not_active Ceased
- 1999-04-28 JP JP2000547071A patent/JP3590586B2/ja not_active Expired - Fee Related
- 1999-04-28 WO PCT/EP1999/002879 patent/WO1999057101A1/en not_active Application Discontinuation
- 1999-04-28 KR KR10-2000-7012375A patent/KR100404256B1/ko not_active IP Right Cessation
- 1999-04-28 DE DE69924480T patent/DE69924480D1/de not_active Expired - Fee Related
- 1999-04-28 CN CNB998060046A patent/CN1147476C/zh not_active Expired - Fee Related
- 1999-04-28 EP EP99923484A patent/EP1075467B1/en not_active Expired - Lifetime
- 1999-04-28 TR TR2000/03256T patent/TR200003256T2/xx unknown
- 1999-04-28 BR BR9911013-0A patent/BR9911013A/pt not_active IP Right Cessation
- 1999-04-28 IL IL13916999A patent/IL139169A0/xx unknown
- 1999-04-28 CA CA002329065A patent/CA2329065A1/en not_active Abandoned
- 1999-04-28 PL PL99344004A patent/PL344004A1/xx not_active Application Discontinuation
- 1999-04-28 RU RU2000130199/04A patent/RU2000130199A/ru not_active Application Discontinuation
- 1999-04-28 NZ NZ507558A patent/NZ507558A/en unknown
- 1999-04-28 ID IDW20002241A patent/ID27535A/id unknown
- 1999-04-28 AT AT99923484T patent/ATE292118T1/de not_active IP Right Cessation
- 1999-04-28 HU HU0101581A patent/HUP0101581A3/hu unknown
- 1999-04-28 YU YU67600A patent/YU67600A/sh unknown
- 1999-05-03 MA MA25567A patent/MA26627A1/fr unknown
- 1999-05-05 TW TW088107268A patent/TW593282B/zh not_active IP Right Cessation
-
2000
- 2000-10-25 HR HR20000724A patent/HRP20000724A2/hr not_active Application Discontinuation
- 2000-11-02 NO NO20005535A patent/NO317985B1/no not_active IP Right Cessation
-
2001
- 2001-11-22 HK HK01108233A patent/HK1037374A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
YU67600A (sh) | 2003-07-07 |
JP3590586B2 (ja) | 2004-11-17 |
AU4034899A (en) | 1999-11-23 |
IL139169A0 (en) | 2001-11-25 |
TW593282B (en) | 2004-06-21 |
ATE292118T1 (de) | 2005-04-15 |
PL344004A1 (en) | 2001-09-10 |
CA2329065A1 (en) | 1999-11-11 |
HUP0101581A3 (en) | 2002-07-29 |
CN1147476C (zh) | 2004-04-28 |
CN1300282A (zh) | 2001-06-20 |
HUP0101581A2 (hu) | 2002-03-28 |
NO317985B1 (no) | 2005-01-17 |
KR20010043363A (ko) | 2001-05-25 |
EP1075467A1 (en) | 2001-02-14 |
KR100404256B1 (ko) | 2003-11-01 |
MA26627A1 (fr) | 2004-12-20 |
WO1999057101A1 (en) | 1999-11-11 |
AU765030B2 (en) | 2003-09-04 |
EP1075467B1 (en) | 2005-03-30 |
NO20005535L (no) | 2000-11-02 |
HK1037374A1 (en) | 2002-02-08 |
NZ507558A (en) | 2003-08-29 |
TR200003256T2 (tr) | 2001-04-20 |
NO20005535D0 (no) | 2000-11-02 |
RU2000130199A (ru) | 2002-11-10 |
HRP20000724A2 (en) | 2001-06-30 |
DE69924480D1 (en) | 2005-05-04 |
BR9911013A (pt) | 2001-02-06 |
JP2002513784A (ja) | 2002-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID27535A (id) | Turunan pirasola sebagai inhibitor p-38 map kinase | |
ATE267200T1 (de) | Bicyclische kinase inhibitoren | |
MXPA02011320A (es) | Derivados de pirazol triciclico como inhibidores de cinasa. | |
BR0014225A (pt) | Derivados de pirazol | |
MXPA03010207A (es) | Nuevas 4-anilinoquinolin-3-carboxamidas. | |
DE69617273T2 (de) | Heterocyclisch substituierte cyclopentanderivate. | |
NO20020925L (no) | N-heterosykliske derivater av NOS-inhibitorer | |
NO20024614D0 (no) | N-heterosykliske derivater som NOS-hemmere | |
ATE300541T1 (de) | Pyrazolopyridinderivate | |
MXPA05013076A (es) | Compuestos de isoindolina-1-ona como inhibidores de cinasa. | |
MXPA05009151A (es) | Inhibidores de cinasa heterociclica. | |
DK1165544T3 (da) | Substituerede 1,4-dihydroindeno[1,2-c]pyrazoler som inhibitorer af tyrosinkinase | |
ATE274515T1 (de) | Pyrazolopyridinderivate | |
ATE246174T1 (de) | Tosylprolin-derivate als thymidylat-synthase inhibitoren | |
ECSP992945A (es) | Derivados de pirazol |